Catalyst Pharmaceuticals Inc (CPRX)
16.18
+0.06
(+0.40%)
USD |
NASDAQ |
May 31, 16:00
16.37
+0.20
(+1.21%)
After-Hours: 20:00
Catalyst Pharmaceuticals Gross Profit (Quarterly): 85.99M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 85.99M |
December 31, 2023 | 94.76M |
September 30, 2023 | 88.52M |
June 30, 2023 | 87.54M |
March 31, 2023 | 75.42M |
December 31, 2022 | 49.56M |
September 30, 2022 | 47.58M |
June 30, 2022 | 45.47M |
March 31, 2022 | 37.20M |
December 31, 2021 | 30.96M |
September 30, 2021 | 30.64M |
June 30, 2021 | 31.82M |
March 31, 2021 | 25.52M |
December 31, 2020 | 26.15M |
September 30, 2020 | 25.44M |
June 30, 2020 | 25.46M |
March 31, 2020 | 24.99M |
December 31, 2019 | 25.72M |
September 30, 2019 | 26.51M |
June 30, 2019 | 24.58M |
March 31, 2019 | 10.74M |
December 31, 2018 | 0.50M |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
24.58M
Minimum
Jun 2019
94.76M
Maximum
Dec 2023
45.49M
Average
31.39M
Median
Gross Profit (Quarterly) Benchmarks
Pfizer Inc | 11.50B |
Sarepta Therapeutics Inc | 362.90M |
PTC Therapeutics Inc | 195.38M |
Corcept Therapeutics Inc | 144.27M |
Cytokinetics Inc | -80.74M |